Background: Voltage-gated potassium channel antibodies (VGKC Ab) are associated with limbic encephalitis and neuromyotonia in adults. There have been no systematic investigations in children to date.
Encephalitis, inflammation of the brain parenchyma, has infectious and immune-mediated etiologies. 1 However, in more than 50% of cases, the cause remains undefined. 2 Recently, there have been descriptions of autoimmune encephalitis associated with specific neuronal autoantibodies. 3 Autoantibodies against voltage-gated potassium channels (VGKC) are found in a proportion of adult patients with immune-responsive limbic encephalitis (LE) and neuromyotonia. [4] [5] [6] With the exception of a case report of a child with temporal lobe epilepsy (TLE) and elevated VGKC antibodies (Ab) 2 years following a suspected LE episode, there have been no descriptions of VGKC encephalitis in children. 7 VGKC Ab are measured by immunoprecipitation of VGKCs extracted from mammalian brain and labeled with 125-I-␣-dendrotoxin that binds specifically to certain VGKC subtypes. However, recent reports suggest that many of the antibodies are directed toward other proteins, such as leucine-rich glioma-inactivated 1 (Lgi1) and contactin-associated protein-like 2 (Caspr2), which are tightly complexed with VGKCs in vivo and in tissue extracts 6, 8 so that antibodies to these VGKC-complex antigens coimmunoprecipitate the 125-I-␣-dendrotoxin-labeled VGKCs. 6 We screened for VGKC Ab by immunoprecipitation in a cohort of children with unex-plained encephalitis presenting with status epilepticus (SE) and refractory seizures, and then asked whether they were directed against Lgi1 or Caspr2.
METHODS We identified 10 patients with unexplained encephalitis presenting with status epilepticus and refractory seizures between 2003 and 2009 (4 boys, mean age 7.5 years, range 1-14 years). All 10 patients had no previous seizures; 8 had no preceding neurologic abnormality and 2 had preceding mild developmental delay. All 10 patients fulfilled the case definition of encephalitis as previously described. 1,2 A case was defined by the presence of encephalopathy (depressed or altered level of consciousness lasting more than 24 hours, lethargy, or change in personality or behavior) with 2 or more of the following symptoms: fever, seizure, focal neurologic findings, CSF pleocytosis, or electroencephalograph or neuroimaging findings consistent with encephalitis. 1, 2 The mean length of hospital stay for the encephalitis event was 19.7 days (median 24.5 days, range 6 -36 days). Nine of the 10 patients (90%) were admitted to the intensive care unit (ICU); the mean length of ICU stay was 9 days (median 5 days, range 2-25 days). The SE was convulsive in all 10 patients, focal in 2, generalized in 5, and secondary generalized in 3. The following results were negative or normal: CSF HSV PCR (n ϭ 8), CSF enterovirus PCR (n ϭ 6), serology for mycoplasma pneumoniae (n ϭ 9), enterovirus (n ϭ 7), cytomegalovirus (n ϭ 6), Epstein-Barr virus (n ϭ 6), herpes simplex virus (n ϭ 5), human herpesvirus 6 (n ϭ 3), influenza (n ϭ 4), and adenovirus (n ϭ 3). The stored serum used for antineuronal antibody testing was acute serum from the first week of the encephalitis admission in all 10 patients. Sera were tested for antibodies to VGKC, NMDAR, GAD, and GlyR with methods currently in use for routine diagnosis. 5, 6, [9] [10] [11] Lgi1 and Caspr2 antibodies were tested using newly developed cell-based assays. 6 The project was approved by the local ethics committee and consent to test the stored serum was obtained from families. The mean length of follow-up was 22 months (median 15.5 months, range 1-66 months). Two patients had ongoing epilepsy, 5 had cognitive impairment, and 1 had died. Only 2 patients were normal on follow-up.
Control group.
To determine the specificity of VGKC autoantibodies in children, we used 69 childhood controls including 15 healthy children (8 male, mean age 11 years, range 9 -13 years), 14 with noninflammatory neurologic disorders (6 male, mean age 7.8 years, range 3-15 years), 19 with immunemediated ataxia (11 male, mean age 6 years, range 1-11 years), 10 with encephalitis lethargica and parkinsonian features (6 male, mean age 9.4 years, range 5-15 years), and 11 with NMDAR encephalitis (2 male, mean age 6.53 years, range 1.3-13 years). 12 The routine laboratory cutoff for VGKC Ab is 100 pM, which is the adult healthy control mean ϩ 3 SD. The mean VGKC Ab in our pediatric healthy control group was 18 pM (SD 26, mean ϩ 3 SD ϭ 96). We therefore used the established cutoff of 100 pM. The VGKC Ab findings in the encephalitis/SE group were compared with the total control group using the Fisher exact nonparametric 2 ϫ 2 test.
RESULTS
Four of 10 patients with encephalitis/SE had a positive VGKC Ab titer (Ͼ100 pM) compared with only 1/69 of the pediatric control group (mean 20 pM, SD 32, p Ͻ 0.001, 95% confidence interval). The positive control (VGKC Ab 173 pM) had NMDAR encephalitis with refractory clinical seizures. The 10 encephalitis/SE patients were all negative for antibodies against Lgi-1, Caspr2, NMDAR, GAD, and GlyR.
The clinical features of the VGKC Ab-positive patients are presented in the table (1 male, age range 1-14 years). All 4 patients were normal before the acute encephalitis, and had SE at presentation. The duration of SE was 30 -60 minutes in one patient, 60 minutes-24 hours in one patient, and longer than 24 hours in 2 patients. Patients had ongoing refractory seizure clusters for 5-20 days with up to 15 seizure clusters per day (table). In addition to seizures, all patients had encephalopathy and behavioral or cognitive alteration during the acute illness. The 4 patients had a mean hospital admission of 20 days (range 7-28 days), and all required admission to intensive care for a mean of 7 days (range 2-18 days). The CSF was abnormal in all 4 VGKC-positive patients with mild pleocytosis (n ϭ 4) and elevated CSF protein (n ϭ 2) (table). CSF PCR for herpes simplex virus and enterovirus was negative in all 3 patients tested. Serology for neurotropic infectious agents was negative. ANA was elevated at 1:640 in 2 patients but resolved on follow-up. One patient (case 1) had hyponatremia (Na 126 mmol/L). Brain MRI showed abnormalities in 2 (table). EEG showed slowing in all 4 patients, generalized in 2 and focal (temporal) in 2. Epileptic activity or electrical seizures were seen in one patient and were of focal (temporal) onset.
The 4 VGKC-positive patients were followed for a mean of 38 months (range 14 -66). Only one made a good recovery: 2 patients had ongoing temporal lobe epilepsy, cognitive impairment, and behavioral/psychological alteration, and one had cognitive impairment only. The patient who made a good recovery (case 4 in the table) is presented in appendix e-1 on the Neurology ® Web site at www.neurology.org. Convalescent MRI showed left mesial temporal sclerosis in case 1 and persistence of the hyperintensities in case 2. Of the 6 VGKC-negative encephalitis patients who were followed up for a mean of 11 months (range 1-20), one has died, 2 have neurodevelopmental disability, and 3 are normal. DISCUSSION VGKC Ab are associated with a form of LE in adults, termed VGKC Ab-associated encephalitis, which is usually seen in patients over 40 years of age. In contrast to the paraneoplastic forms of LE, this form of LE is usually nonparaneoplastic and thought to be immune responsive with a good outcome if treated adequately. [4] [5] [6] Our retrospective study suggests an encephalitis associated with VGKC Ab exists in children and is characterized by encephalitis with seizures and cognitive and behavioral alteration. VGKC Ab detection is performed on serum rather than CSF, as CSF levels are usually relatively low and sometimes negative. The VGKC Ab assay measures immunoglobulin G (IgG) rather than immunoglobulin M (IgM). Longitudinal studies of VGKC IgG and IgM would help understand the evolution of the autoimmune process relative to the clinical encephalitis. Although these patients had elevated VGKC Ab, they did not have antibodies to Lgi1 or Caspr2, suggesting that these pediatric patients are different from the LE associated with Lgi1 antibodies described recently in adults. 6, 8 Further analysis of their sera is in progress to determine whether their antibodies are directed against the VGKC subunits or other proteins in the VGKC complex. Our control group suggest that elevated VGKC Ab are rare in children: the only control with an elevated VGKC Ab titer had a clinical phenotype of NMDAR encephalitis and had both NMDAR and VGKC Ab. 12 The finding of more than one antibody associated with autoimmune encephalitis has been recently reported in an adult patient. 13 The encephalitis in these patients was previously unexplained and CSF testing for common infectious agents and serologic investigations were negative. As the diagnosis of VGKC Ab-associated encephalitis was made retrospectively using stored acute serum, none of our patients received immunotherapy during the acute illness. The 4 VGKC Ab patients have generally done poorly: 2 patients have ongoing TLE and one has cognitive impairment. Prospective studies including longitudinal VGKC Ab measurement before and after immune therapy are required to improve our understanding of VGKC encephalitis in children.
The initial clinical course of case 4 was reminiscent of devastating epileptic encephalopathy in school-aged children (DESC). DESC is a pseudoencephalitis syndrome of unknown cause that affects previously well children, causes refractory seizures and encephalopathy, and has severe morbidity and mortality. 14 The cases are also reminiscent of acute encephalitis with refractory, repetitive partial seizures (AERRPS), an unexplained encephalitis associated with seizures which is described mainly in Japanese patients. 15 It is possible that autoimmune mechanisms may be important in some cases of DESC and AERRPS, and this requires investigation.
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